A comparison of conditional random fields and structured support vector machines for chemical entity recognition in biomedical literature.
Analysis of pharmacogenomic variants associated with population differentiation.
ONRLDB--manually curated database of experimentally validated ligands for orphan nuclear receptors: insights into new drug discovery.
Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis.
Physicochemical characteristics of structurally determined metabolite-protein and drug-protein binding events with respect to binding specificity.
Optimizing drug-target interaction prediction based on random walk on heterogeneous networks.
Cancer based pharmacogenomics network supported with scientific evidences: from the view of drug repurposing.
Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.
Assessing the Need of Discourse-Level Analysis in Identifying Evidence of Drug-Disease Relations in Scientific Literature.
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.